GREY:IMVIF - Post by User
Post by
Breakthorough1on Aug 15, 2023 3:15pm
119 Views
Post# 35589613
August 11 2022
August 11 2022“Starting with an early look at our VITALIZE data in the third quarter of 2022 and continuing through mid-2023, we expect to communicate results and translational data from all our active clinical trials that, we believe, will further validate the efficacy and safety of MVP-S. These data should bolster the enthusiasm around the unique capabilities of our delivery platform to make cancer vaccines clinically viable.”